---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-118497"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:10:13.165517+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals prices $85M offering of common stock and pre-funded warrants at $3.65/share

## Summary
- Gross proceeds ~$85M; net proceeds ~$79.5M after underwriting discounts and expenses.
- Offering: 18,356,173 common shares at $3.65 plus pre-funded warrants for 4,931,507 shares at $3.649.
- Investors include BVF Partners, RA Capital, Frazier Life Sciences, Blue Owl, First Light, Sphera, Woodline, Nantahala, and T1D Fund.
- Proceeds to be used for advancing pipeline, working capital, and general corporate purposes.
- Closing expected on or about October 30, 2024; 90-day lock-up for executives and directors.

## SEC filing metadata
- accession: 0000950170-24-118497
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/0000950170-24-118497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/eldn-20241029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-118497
- JSON: https://secwatch.observer/filing/0000950170-24-118497.json
- Plain text: https://secwatch.observer/filing/0000950170-24-118497.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.